Prevention of ventilator-associated pneumonia or ventilator-associated complications: A worthy, yet challenging, goal

Critical Care Medicine

Volumn 40, Issue 1, 2012, Pages 271-277

  Kollef, Marin H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Infection; Prevention; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTIFICIAL VENTILATION; CLINICAL PROTOCOL; DEEP VEIN THROMBOSIS; ENDOTRACHEAL TUBE; GASTRITIS; GLOVE; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; NASOGASTRIC TUBE; PRIORITY JOURNAL; REVIEW; STRESS ULCER; VENTILATOR ASSOCIATED PNEUMONIA;

HUMANS; PNEUMONIA, VENTILATOR-ASSOCIATED; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE; RESPIRATION, ARTIFICIAL; UNITED STATES;

EID: 84055160861     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318232e41d     Document Type: Review

References (68)

1. Nguile-Makao M, Zahar JR, Francais A, et al: Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med 2010; 36:781-789
2. Shorr AF, Zilberberg MD, Kollef M: Costeffectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia. Infec Control Hosp Epidemiol 2009; 30:759-763
3. Warren DK, Shukla SJ, Olsen MA, et al: Outcome and attributable cost of ventilatorassociated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003; 31:1312-1317
4. Arias CA, Murray BE: Antibiotic-resistant bugs in the 21st century-A clinical superchallenge. N Engl J Med 2009; 360:439-443
5. Chung R, Song J-H, Kim SH, et al: High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med 2011 Sep
6. Vincent JL, Rello J, Marshall J, et al: International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302:2323-2329
7. Kollef KE, Schramm GE, Wills AR, et al: Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 2008; 134:281-287
8. Centers for Disease Control and Prevention (CDC): Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase-United States, 2010. MMWR Morb Mortal Wkly Rep 2010; 59:750
9. Kollef MH, Sherman G, Ward S, Fraser VJ: Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462-474
10. Dhainaut JF, Laterre PF, LaRosa SP, et al: The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results. Crit Care Med 2003; 31:2291-2301
11. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al: Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31:2742-2751
12. Harbarth S, Garbino J, Pugin J, et al: Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115:529-535
13. Ferrer R, Artigas A, Suarez D, et al: Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study. Am J Respir Crit Care Med 2009; 180:861-866
14. Boucher H, Talbot GH, Bradley JS, et al: Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1-12
15. Kollef MH: Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis 2008; 47:S3-S13
16. Johnson MT, Reichley R, Hoppe-Bauer J, et al: Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis. Crit Care Med 2011 Apr 14. [Epub ahead of print]
17. Morrow LE, Kollef MH: Recognition and prevention of nosocomial pneumonia in the intensive care unit and infection control in mechanical ventilation. Crit Care Med 2010; 38:S352-S362
18. Tejerina E, Esteban A, Fernandez-Segoviano P, et al: Accuracy of clinical definitions of ventilator-associated pneumonia: Comparison of autopsy findings. J Crit Care 2010; 25:62-68
19. Rea-Neto A, Youssef NC, Tuche F, et al: Diagnosis of ventilator- associated pneumonia: A systematic review of the literature. Crit Care 2008; 12:R56
20. Vincent JL, de Souza Barros D, Cianferoni S Diagnosis, management, and prevention of ventilator-associated pneumonia. Drugs 2010; 1927-1944
21. Wunderink RG, Woldenberg LS, Zeiss J, et al: The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest 1992; 101:458-463
22. Pingleton SK, Fagon JY, Leeper KV Jr: Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques. Chest 1992; 102:553S-556S.
23. American Thoracic Society, Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcareassociated pneumonia. Am J Respir Crit Care Med 2005; 71:388-416
24. Centers for Disease Control and Prevention: National Nosocomial Infections Surveillance System (NNIS). Available online at http://www.cdc.gov/ ncidod/dhqp/nnis.html. Accessed: June 6, 2011
25. Miller PR, Johnson JC III, Karchmer T, et al: National nosocomial infection surveillance system: From benchmark to bedside in trauma patients. J Trauma 2006; 60:98-103
26. Skrupky L, McConnell K, Dallas J, et al: A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria. Crit Care Med 2011 Sep 15. [Epub ahead of print]
27. Torres A, Fabregas N, Ewig S, et al: Sampling methods for ventilator-associated pneumonia: Validation using different histologic and microbiological references. Crit Care Med 2000; 28:2799-2804
28. Balthazar AB, Von Nowakonski A, De Capitani EM, et al: Diagnostic investigation of ventilator-associated pneumonia using bronchoalveolar lavage: Comparative study with a postmortem lung biopsy. Braz J Med Biol Res 2001; 34:993-1001
29. Torres A, el-Ebiary M, Padró L, et al: Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med 1994; 149:324-331
30. Torres A, El-Ebiary M, Fábregas N, et al: Value of intracellular bacteria detection in the diagnosis of ventilator associated pneumonia. Thorax 1996; 51:378-384
31. Kirtland SH, Corley DE, Winterbauer RH, et al: The diagnosis of ventilator-associated pneumonia: A comparison of histologic, microbiologic, and clinical criteria. Chest 1997; 112:445-457
32. Marquette CH, Copin MC, Wallet F, et al: Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 1995; 151:1878-1888
33. Papazian L, Autillo-Touati A, Thomas P, et al: Diagnosis of ventilator-associated pneumonia: An evaluation of direct examination and presence of intracellular organisms. Anesthesiology 1997; 87:268-276
34. Rouby JJ, Rossignon MD, Nicolas MH, et al: A prospective study of protected bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. Anesthesiology 1989; 71: 679-685
35. Fàbregas N, Ewig S, Torres A, et al: Clinical diagnosis of ventilator associated pneumonia revisited: Comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54:867-873
36. Riaz OJ, Malhotra AK, Aboutanos MB, et al: Bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia: to quantitate or not, that is the question. Am Surg 2011; 77:297-303
37. Fagon JY, Chastre J, Wolff M, et al: Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000; 132:621-630
38. Shorr AF, Sherner JH, Jackson WL, et al: Invasive approaches to the diagnosis of ventilator-associated pneumonia: A metaanalysis. Crit Care Med 2005; 33:46-53
39. Ibrahim EH, Ward S, Sherman G, et al: Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29:1109-1115
40. Dellit TH, Chan JD, Skerrett SJ, et al: Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices. Infect Control Hosp Epidemiol 2008; 29:525-533
41. Bouadma L, Luyt CE, Tubach F, et al: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial. Lancet 2010; 375:463-474
42. Micek ST, Ward S, Fraser VJ, et al: A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004; 125:1791-1799
43. Singh N, Rogers P, Atwood CW, et al: Shortcourse empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162:505-151
44. Klompas M, Khan Y, Kleinman K, et al: Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation. PLoS One 2011; 6:e18062
45. Public Health Prevention Fund: Streamlined surveillance for ventilator-associated pneumonia: reducing burden and demonstrating preventability. Available at: http://www.grants.gov/search/search.do?oppId- 84773&mode-VIEW. Accessed June 5, 2011
46. Uckay I, Ahmed QA, Sax H, et al: Ventilatorassociated pneumonia as a quality indicator for patient safety? Clin Infect Dis 2008; 46: 557-563
47. Zack JE, Garrison T, Trovillion E, et al: Effect of an education program aimed at reducing the occurrence of ventilatorassociated pneumonia. Crit Care Med 2002; 30:2407-2412
48. Babcock HM, Zack JE, Garrison T, et al: An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: A comparison of effects. Chest 2004; 125:2224-2231
49. Apisarnthanarak A, Pinitchai U, Thongphubeth K, et al: Effectiveness of an educational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: A 4-year study. Clin Infect Dis 2007; 45:704-711
50. Lansford T, Moncure M, Carlton E, et al: Efficacy of a pneumonia prevention protocol in the reduction of ventilator-associated pneumonia in trauma patients. Surg Infect 2007; 8:505-510
51. Sona CS, Zack JE, Schallom ME, et al: The impact of a simple, low-cost oral care protocol on ventilator-associated pneumonia rates in a surgical intensive care unit. J Intensive Care Med 2009; 24:54-62
52. Kollef MH: Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004; 32:1396-1405
53. DuBose JJ, Inaba K, Shiflett A, et al: Measurable outcomes of quality improvement in the trauma intensive care unit: the impact of a daily quality rounding checklist. J Trauma 2008; 64:22-27
54. Wahl WL, Talsma A, Dawson C, et al: Use of computerized ICU documentation to capture ICU core measures. Surgery 2006; 140: 684-689
55. Bouadma L, Mourvillier B, Deiler V, et al: A multifaceted program to prevent ventilatorassociated pneumonia: Impact on compliance with preventive measures. Crit Care Med 2010; 38:789-796
56. Pittet D, Zingg W: Reducing ventilatorassociated pneumonia: When process control allows outcome improvement and even benchmarking. Crit Care Med 2010; 38: 983-984
57. Institute for Healthcare Improvement: Available at: http://www.ihi.org. Accessed June 3, 2011
58. Zilberberg MD, Shorr AF, Kollef MH: Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit Care Med 2009; 37:305-309
59. Kollef MH, Afessa B, Anzueto A, et al: Silvercoated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008; 20:300: 805-813
60. Lorente L, Blot S, Rello J, et al: New issues and controversies in the prevention of ventilator-associated pneumonia. Am J Respir Crit Care Med 2010; 182:870-876
61. Heimes J, Braxton C, Nazir N, et al: Implementation and enforcement of ventilatorassociated pneumonia prevention strategies in trauma patients. Surg Infect 2011; 12: 99-103
62. Rewa O, Muscedere J: Ventilator-associated pneumonia: Update on etiology, prevention, and management. Curr Infect Dis Rep 2011; 13:287-295
63. Kollef M: SMART approaches for reducing nosocomial infections in the ICU. Chest 2008; 134:447-456
64. Bouadma L, Deslandes E, Lolom I, et al: Long-term impact of a multifaceted preventive program on ventilator-associated pneumonia in a medical intensive care unit. Clin Infect Dis 2010; 51:1115-1122
65. Doyle Jim. Saint Louis Today. December 31, 2010. Available at: http://www.stltoday.com/business/local/article-679416e5-c294-5340-8f2d- 2d6eb727470b.html. Accessed June 7, 2011
66. Klompas M: Ventilator-associated pneumonia: is zero possible? Clin Infect Dis 2010; 51:1123-1126
67. Chastre J, Wolff M, Fagon JY, et al: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 2003; 290: 2588-2598
68. Bouza E, Perez MJ, Munoz P, et al: Continuous aspiration of subglottic secretions in the prevention of ventilator-associated pneumonia in the postoperative period of major heart surgery. Chest 2008; 134: 938-946